Target intelligence / Profile preview

E-site of the 60S eukaryotic ribosomal subunit (60S E-site)

Target
60S E-site
Molecular classification
Ribonucleoprotein complex, Ribosomal subunit, Translation machinery
01

Overview

The E-site of the 60S eukaryotic ribosomal subunit is a critical functional domain within the large ribosomal subunit responsible for the release of deacylated tRNA during protein synthesis (Wilson & Doudna Cate, 2012). As one of the three primary tRNA binding sites (A, P, and E), the E-site facilitates the final stage of the translation elongation cycle by holding the tRNA after its amino acid has been added to the growing polypeptide chain (Garreau de Loubresse et al., 2014). This site is structurally complex, involving interactions between ribosomal RNA (rRNA) and various ribosomal proteins, and its proper functioning is essential for the translocation of the mRNA-tRNA complex. In clinical and research contexts, the 60S E-site is a significant pharmacological target; for instance, the antifungal agent Sordarin selectively inhibits fungal protein synthesis by stabilizing the interaction between elongation factor 2 (eEF2) and the E-site (Justice et al., 1998). Similarly, the laboratory tool cycloheximide exerts its inhibitory effects by binding directly to this site, preventing the release of tRNA and halting translation (Schneider-Poetsch et al., 2010). Understanding the E-site's architecture and dynamics is vital for developing selective inhibitors that can distinguish between fungal and human ribosomes, thereby addressing infectious diseases while minimizing host toxicity. Dysregulation of ribosomal function at this site is also implicated in various ribosomopathies and the hyper-proliferative state of cancer cells (Robert et al., 2009).

Other names
Ribosomal exit site60S exit siteE-site of the large ribosomal subunittRNA exit site
02

Mechanism of action

Inhibition of translation elongation by blocking deacylated tRNA release or stabilizing elongation factor binding to the exit site (Schneider-Poetsch et al., 2010; Justice et al., 1998).

03

Biological functions

Protein translationTranslation elongationtRNA deacylation and releasemRNA-tRNA translocation
04

Disease associations

Fungal infectionCancerRibosomopathy
05

Safety considerations

CytotoxicityLack of species selectivityInhibition of mitochondrial translationBone marrow suppression
06

Interacting drugs

Cycloheximide

4 more in the full profile.

07

Biomarkers

Ribosomal protein L44 (uL15) mutationseEF2 phosphorylation statusProtein synthesis rate

Beyond the preview

Go deeper on E-site of the 60S eukaryotic ribosomal subunit (60S E-site).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on E-site of the 60S eukaryotic ribosomal subunit (60S E-site).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call